Displaying 96 (all) recruiting clinical trials.
-
OPTIMICE-PCR: DE-ESCALATION OF THERAPY IN EARLY-STAGE TNBC PATIENTS WHO ACHIEVE PCR AFTER NEOADJUVANT CHEMOTHERAPY WITH CHECKPOINT INHIBITOR THERAPY
This study is for patients with early-stage triple-negative breast cancer who received a treatment called pembrolizumab (a medicine used to treat melanoma). Some patients will ...Phase
Interventional
-
A randomized double-blind placebo-controlled Phase 3 study of darolutamide plus androgen deprivation therapy (ADT) compared with placebo plus ADT in patients with high-risk biochemical recurrence (BCR) of prostate cancer
This is a research study that aims to determine if adding darolutamide to the standard treatment, ADT (referred to as androgen deprivation therapy which is ...
Phase
Interventional
-
A Phase 3 Multi-center Randomized Withdrawal and Long-Term Extension Study of Ampreloxetine for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Participants with Multiple System Atrophy
The purpose of this research is to study whether an investigational drug, called ampreloxetine, works and how safe it is when taken over several months ...Phase
Interventional
-
A Clinical Research Study for Children Teens and Young Adults Diagnosed With Dravet Syndrome The Skyline Study
The Skyline Study is a Phase 3 clinical research study of an investigational medication for children, teens, and young adults diagnosed with Dravet syndrome who ...Phase
Interventional
-
Duration and Efficacy of Azstarys (serdexmethylphenidate and dexmethylphenidate) on Adult ADHD Symptoms and Executive Function In Early Evening
The purpose of this open-label treatment study is to extend the safety and efficacy evidence basis for Azstarys, a recently FDA approved ADHD product, in ...Phase
Interventional
-
Safety and Efficacy of Empagliflozin in Hemodialysis (SEED)
The purpose of this research study is to explore the safety and efficacy of a drug called empagliflozin (EMPA) in reducing kidney and cardiovascular events ...Phase
Interventional
